Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | isocitrate dehydrogenase (NAD) subunit | 0.0034 | 0.0054 | 0.0125 |
Mycobacterium ulcerans | glutaminase | 0.0273 | 0.2218 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0506 | 0.4327 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0358 | 0.299 | 0.299 |
Schistosoma mansoni | hypothetical protein | 0.0358 | 0.299 | 0.4426 |
Chlamydia trachomatis | two component regulatory system sensor histidine kinase | 0.0028 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0057 | 0.0264 | 0.039 |
Mycobacterium tuberculosis | Probable 3-isopropylmalate dehydrogenase LeuB (beta-IPM dehydrogenase) (IMDH) (3-IPM-DH) | 0.0034 | 0.0054 | 0.0236 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0201 | 0.0201 |
Schistosoma mansoni | tar DNA-binding protein | 0.0256 | 0.2059 | 0.3048 |
Schistosoma mansoni | tar DNA-binding protein | 0.0256 | 0.2059 | 0.3048 |
Echinococcus multilocularis | tar DNA binding protein | 0.0256 | 0.2059 | 0.4758 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0281 | 0.2288 | 0.5288 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0281 | 0.2288 | 0.5288 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.0057 | 0.0264 | 0.0264 |
Echinococcus granulosus | isocitrate dehydrogenase NAD | 0.0034 | 0.0054 | 0.0125 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0256 | 0.2059 | 0.2059 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0774 | 0.6755 | 0.6755 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0281 | 0.2288 | 0.5288 |
Loa Loa (eye worm) | hypothetical protein | 0.0774 | 0.6755 | 0.6755 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0281 | 0.2288 | 0.5288 |
Echinococcus granulosus | GPCR family 2 | 0.0358 | 0.299 | 0.691 |
Loa Loa (eye worm) | TAR-binding protein | 0.0256 | 0.2059 | 0.2059 |
Trichomonas vaginalis | glutaminase, putative | 0.0273 | 0.2218 | 1 |
Brugia malayi | isocitrate dehydrogenase [NAD] subunit beta, mitochondrial | 0.0034 | 0.0054 | 0.0054 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0478 | 0.4072 | 0.6028 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0281 | 0.2288 | 0.5288 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0264 | 0.0264 |
Brugia malayi | RNA binding protein | 0.0256 | 0.2059 | 0.2059 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0281 | 0.2288 | 1 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0281 | 0.2288 | 0.2288 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0358 | 0.299 | 0.691 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.1133 | 1 | 1 |
Brugia malayi | Isocitrate dehydrogenase subunit gamma, mitochondrial precursor | 0.0034 | 0.0054 | 0.0054 |
Schistosoma mansoni | hypothetical protein | 0.0774 | 0.6755 | 1 |
Brugia malayi | glutaminase DH11.1 | 0.0273 | 0.2218 | 0.2218 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.005 | 0.0201 | 0.088 |
Brugia malayi | Isocitrate dehydrogenase | 0.0281 | 0.2288 | 0.2288 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.005 | 0.0201 | 0.088 |
Schistosoma mansoni | tar DNA-binding protein | 0.0256 | 0.2059 | 0.3048 |
Schistosoma mansoni | glutaminase | 0.0273 | 0.2218 | 0.3283 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0506 | 0.4327 | 1 |
Schistosoma mansoni | isocitrate dehydrogenase | 0.0034 | 0.0054 | 0.008 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.005 | 0.0201 | 0.0465 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0054 | 0.0054 |
Brugia malayi | isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial | 0.0034 | 0.0054 | 0.0054 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0478 | 0.4072 | 0.6028 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0281 | 0.2288 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0057 | 0.0264 | 0.039 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0281 | 0.2288 | 0.5288 |
Brugia malayi | isocitrate dehydrogenase | 0.0281 | 0.2288 | 0.2288 |
Treponema pallidum | chemotaxis histidine kinase (cheA) | 0.0028 | 0 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0256 | 0.2059 | 0.2059 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0281 | 0.2288 | 0.5288 |
Giardia lamblia | Heat shock protein HSP 90-alpha | 0.0028 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0358 | 0.299 | 0.4426 |
Loa Loa (eye worm) | hypothetical protein | 0.1133 | 1 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0358 | 0.299 | 0.691 |
Trichomonas vaginalis | isocitrate dehydrogenase, putative | 0.0034 | 0.0054 | 0.0243 |
Brugia malayi | kinase, mitochondrial precursor | 0.0506 | 0.4327 | 0.4327 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0358 | 0.299 | 0.299 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0506 | 0.4327 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0178 | 0.1358 | 0.1358 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0506 | 0.4327 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0256 | 0.2059 | 0.2059 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0178 | 0.1358 | 1 |
Brugia malayi | Probable isocitrate dehydrogenase | 0.0034 | 0.0054 | 0.0054 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.0057 | 0.0264 | 0.0609 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.005 | 0.0201 | 0.0465 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0358 | 0.299 | 0.691 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.0057 | 0.0264 | 0.0609 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0358 | 0.299 | 0.299 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0358 | 0.299 | 0.691 |
Schistosoma mansoni | hypothetical protein | 0.0057 | 0.0264 | 0.039 |
Giardia lamblia | Pms1-like protein | 0.0028 | 0 | 0.5 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.0057 | 0.0264 | 0.0264 |
Loa Loa (eye worm) | hypothetical protein | 0.0506 | 0.4327 | 0.4327 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0358 | 0.299 | 0.691 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.005 | 0.0201 | 0.088 |
Toxoplasma gondii | pyruvate dehydrogenase kinase, putative | 0.0177 | 0.1347 | 0.5887 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.0057 | 0.0264 | 0.0609 |
Echinococcus granulosus | isocitrate dehydrogenase NAD subunit | 0.0034 | 0.0054 | 0.0125 |
Brugia malayi | Probable isocitrate dehydrogenase | 0.0034 | 0.0054 | 0.0054 |
Entamoeba histolytica | tartrate dehydrogenase, putative | 0.0034 | 0.0054 | 1 |
Brugia malayi | hypothetical protein | 0.005 | 0.0201 | 0.0201 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0281 | 0.2288 | 1 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.0057 | 0.0264 | 0.0609 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0281 | 0.2288 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0358 | 0.299 | 0.4426 |
Leishmania major | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0177 | 0.1347 | 0.3113 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.1133 | 1 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0506 | 0.4327 | 1 |
Schistosoma mansoni | unc-13 (munc13) | 0.0034 | 0.0054 | 0.008 |
Mycobacterium ulcerans | 3-isopropylmalate dehydrogenase | 0.0034 | 0.0054 | 0.0243 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0281 | 0.2288 | 0.5288 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.0028 | 0 | 0.5 |
Trypanosoma cruzi | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0177 | 0.1347 | 0.3113 |
Loa Loa (eye worm) | isocitrate dehydrogenase gamma subunit | 0.0034 | 0.0054 | 0.0054 |
Loa Loa (eye worm) | glutaminase | 0.0273 | 0.2218 | 0.2218 |
Echinococcus multilocularis | isocitrate dehydrogenase (NAD+) | 0.0034 | 0.0054 | 0.0125 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.0057 | 0.0264 | 0.039 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0506 | 0.4327 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0256 | 0.2059 | 0.3048 |
Schistosoma mansoni | apoptosis regulator bax | 0.0057 | 0.0264 | 0.039 |
Trypanosoma brucei | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0177 | 0.1347 | 0.3113 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.005 | 0.0201 | 0.0465 |
Loa Loa (eye worm) | glutaminase 2 | 0.0273 | 0.2218 | 0.2218 |
Schistosoma mansoni | tar DNA-binding protein | 0.0256 | 0.2059 | 0.3048 |
Mycobacterium leprae | PROBABLE 3-ISOPROPYLMALATE DEHYDROGENASE LEUB (BETA-IPM DEHYDROGENASE) (IMDH) (3-IPM-DH) | 0.0034 | 0.0054 | 1 |
Schistosoma mansoni | Isocitrate dehydrogenase [NAD] subunit gamma mitochondrial | 0.0034 | 0.0054 | 0.008 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0281 | 0.2288 | 0.3387 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.0028 | 0 | 0.5 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0205 | 0.1602 | 0.7001 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0281 | 0.2288 | 0.5288 |
Schistosoma mansoni | hypothetical protein | 0.0358 | 0.299 | 0.4426 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0281 | 0.2288 | 0.5288 |
Brugia malayi | N-terminal motif family protein | 0.0178 | 0.1358 | 0.1358 |
Treponema pallidum | DNA gyrase, subunit B (gyrB) | 0.0028 | 0 | 0.5 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0506 | 0.4327 | 0.6405 |
Leishmania major | hypothetical protein, conserved | 0.005 | 0.0201 | 0.0465 |
Echinococcus granulosus | tar DNA binding protein | 0.0256 | 0.2059 | 0.4758 |
Brugia malayi | hypothetical protein | 0.0033 | 0.004 | 0.004 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0281 | 0.2288 | 0.5288 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.005 | 0.0201 | 0.088 |
Loa Loa (eye worm) | hypothetical protein | 0.0358 | 0.299 | 0.299 |
Leishmania major | isocitrate dehydrogenase, putative | 0.0034 | 0.0054 | 0.0125 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0281 | 0.2288 | 1 |
Wolbachia endosymbiont of Brugia malayi | isocitrate dehydrogenase | 0.0034 | 0.0054 | 1 |
Brugia malayi | TAR-binding protein | 0.0256 | 0.2059 | 0.2059 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.